Nov 21, 2024 1:37 PM
BACK TO TOP
KSE100
97,056.13
1509.68
(1.58%)
ALLSHR
61,789.35
607.18
(0.99%)
KSE30
30,084.60
506.60
(1.71%)
KMI30
145,697.66
1201.97
(0.83%)
BKTI
22,120.80
52.68
(0.24%)
OGTI
23,635.82
-26.67
(-0.11%)
KMIALLSHR
42,393.16
318.93
(0.76%)
PSXDIV20
37,682.99
470.97
(1.27%)
UPP9
29,375.96
746.07
(2.61%)
NITPGI
23,479.49
425.42
(1.85%)
NBPPGI
26,315.81
418.38
(1.62%)
MZNPI
19,350.73
197.31
(1.03%)
JSMFI
28,334.76
545.27
(1.96%)
ACI
15,062.76
81.29
(0.54%)
JSGBKTI
24,696.09
67.49
(0.27%)
MII30
13,701.03
126.65
(0.93%)
HBLTTI
15,183.43
01-11-2024
8.25
(0.05%)
Ferozsons Laboratories Limited
PHARMACEUTICALS
Rs.348.10
2.35
(0.68%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Thu, Nov 21, 2024 1:34 PM
REG
FUT
ODL
Open
346.00
High
352.05
Low
338.00
Volume
244,968
CIRCUIT BREAKER
311.18 — 380.33
DAY RANGE
338.00 — 352.05
52-WEEK RANGE
190.00 — 362.95
Ask Price
349.97
Ask Volume
50
Bid Price
348.00
Bid Volume
1,019
LDCP
345.75
VAR
13.00
HAIRCUT
25.00
P/E Ratio (TTM) **
42.04
1-Year Change *
63.98%
YTD Change *
57.77%
Last update: Tue, Nov 5, 2024 4:00 PM
Open
0.00
High
0.00
Low
0.00
Close
313.84
Change
0.00%
LDCP
359.02
Volume
0
Total Trades
0
CIRCUIT BREAKER
323.12 — 394.92
DAY RANGE
0.00 — 0.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
Last update: Thu, Nov 21, 2024 1:32 PM
Open
342.00
High
350.00
Low
342.00
Close
350.00
Change
0.43%
LDCP
348.50
Volume
4,000
Total Trades
7
CIRCUIT BREAKER
313.65 — 383.35
DAY RANGE
342.00 — 350.00
Ask Price
350.00
Ask Volume
2,000
Bid Price
335.36
Bid Volume
500
Last update: Tue, Nov 5, 2024 4:00 PM
Open
0.00
High
0.00
Low
0.00
Close
307.80
Change
0.00%
LDCP
352.57
Volume
0
Total Trades
0
CIRCUIT BREAKER
317.31 — 387.83
DAY RANGE
0.00 — 0.00
Ask Price
355.00
Ask Volume
2,500
Bid Price
335.00
Bid Volume
1,000

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Ferozsons Laboratories Limited was incorporated as a private limited company on 28 January 1954 and was converted into a public limited company on 08 September 1960. The Company is primarily engaged in the imports, manufacture and sale of pharmaceutical products and medical devices.

KEY PEOPLE
Osman Khalid WaheedCEO
Akhter Khalid WaheedChairperson
Syed Ghausuddin SaifCompany Secretary
ADDRESS

Ferozsons Laboratories Limited 197-A, The Mall Rawalpindi, Pakistan.

WEBSITE

www.ferozsons-labs.com

REGISTRAR

CorpTec Associates (Pvt.) Limited, 503-E, Johar Town, Lahore

AUDITOR

KPMG Taseer Hadi & Co. Chartered Accountants

Equity Profile

Market Cap (000's)
15,131,576.65
Shares
43,469,051
Free Float
17,387,621
Free Float
40.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 30, 2024Transmission of Quarterly Report for the Period Ended 2024-09-30 View   PDF
Oct 28, 2024Financial Results for the Quarter Ended 2024-09-30 View   PDF
Oct 7, 2024Transmission of Annual Report for the Year Ended 2024-06-30 View   PDF
Oct 4, 2024Financial Results for the Year Ended 2024-06-30 View   PDF
Apr 30, 2024Transmission of Quarterly Report for the Period Ended 2024-03-31 View   PDF
Apr 26, 2024Financial Results for the Quarter Ended 2024-03-31 View   PDF
Feb 29, 2024Transmission of Quarterly Report for the Period Ended 2023-12-31 View   PDF
Feb 28, 2024Financial Results for the Quarter Ended 2023-12-31 View   PDF
Oct 30, 2023Transmission of Quarterly Report for the Period Ended 30-09-2023 View   PDF
Oct 30, 2023Financial Results for the Quarter Ended 30-09-2023 View   PDF
DateTitleDocument
Oct 28, 2024Certified True Copies of the Resolutions passed in the 68th Annual General Meeting of the Company View   PDF
Oct 21, 2024Board Meeting View   
Oct 7, 2024Notice of Annual General Meeting View   PDF
Oct 7, 2024Notice of Annual General Meeting prior to publication View   PDF
Sep 27, 2024Board Meeting View   
Apr 18, 2024Board Meeting View   
Feb 21, 2024Board Meeting View   
Feb 6, 2024Emergent Board Meeting other than Financial Results View   
Oct 30, 2023Certified True Copy of the Resolutions passed in the 67th Annual General Meeting of the Company View   PDF
Oct 19, 2023Board Meeting View   
DateTitleDocument
Nov 8, 2024Credit of Final Cash Dividend View   
Oct 18, 2024Addendum to AGM Notice View   PDF
Oct 15, 2024Postal Ballot Paper Published in Newspapers View   PDF
Oct 14, 2024Postal Ballot Paper prior to publication in Newspaper View   PDF
Oct 3, 2024Material Information View   PDF
Sep 9, 2024Material Information View   PDF
Sep 4, 2024Material Information View   
Aug 15, 2024Material Information View   PDF
May 22, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Apr 4, 2024Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2024202320222021
Sales12,711,7149,893,3917,806,4147,033,622
Profit after Taxation400,054189,042514,149725,235
EPS9.204.3511.8320.02
Q1 2025Q3 2024Q2 2024Q1 2024
Sales3,356,5792,848,2753,087,9113,622,967
Profit after Taxation140,51113,31976,538180,516
EPS3.230.311.764.15
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2024202320222021
Gross Profit Margin (%)38.8838.6345.0641.04
Net Profit Margin (%)3.151.916.5910.31
EPS Growth (%)111.49(63.23)(40.91)83.33
PEG0.24(0.50)(0.56)0.21

Payouts

DateFinancial ResultsDetailsBook Closure
October 4, 2024 4:27 PM30/06/2024(YR) 30%(F) (D) 22/10/2024 - 28/10/2024
August 31, 2022 3:53 PM30/06/2022(YR) 20% (B) - 50% (D) 23/09/2022 - 30/09/2022
August 31, 2021 12:24 PM30/06/2021(YR) 100%(F) (D) 24/09/2021 - 30/09/2021
September 24, 2020 3:07 PM30/06/2020(YR) 40%(F) (D) - 20% (B) 17/10/2020 - 26/10/2020
September 23, 2019 2:47 PM30/06/2019(YR) 40%(F) (D) 18/10/2019 - 25/10/2019
February 25, 2019 12:50 PM31/12/2018(HYR) 20% (i) (D) 08/03/2019 - 14/03/2019
September 25, 2018 3:08 PM30/06/2018(YR) 20% (D) 20/10/2018 - 27/10/2018
August 30, 2017 3:38 PM30/06/2017(YR) 40% (D) M /10/2017 - 18/10/2017
January 30, 2017 3:47 PM31/12/2016(HYR) 30%(I) (D) 11/02/2017 - 19/02/2017
August 30, 2016 10:16 AM30/06/2016(YR) 120% (F) (D) 11/10/2016 - 20/10/2016

Financial Reports